Skip to main content
Year archive

Abliva — 2018 filings

All 57 regulatory filings released by Abliva (ABLI) in 2018, sourced directly from the official regulator.

57 Filings
2018 Period
2018 filings (57)
Filing Released Lang
Amended number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2018-12-28 English
Ändring av antal aktier och röster i NeuroVive Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2018-12-28 Swedish
Kallelse till extra bolagsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2018-12-11 Swedish
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
AGM Information
2018-12-11 English
Kallelse till extra bolagsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2018-12-10 Swedish
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
AGM Information
2018-12-10 English
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-22 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-22 English
NeuroVive erhåller Vinnova-anslag till stöd för utvecklingen av NV354, en ny behandling av genetisk mitokondriell sjukdom
Capital/Financing Update
2018-11-15 Swedish
NeuroVive receives Vinnova funding to support development of NV354, a novel treatment for genetic mitochondrial disorders
Regulatory Filings
2018-11-15 English
NeuroVive meddelar idag att teckningstiden för teckningsoptioner av serie 2018:1 inleds på torsdag den 1 november
Share Issue/Capital Change
2018-10-31 Swedish
NeuroVive today announces that the subscription period for warrants of series 2018:1 will begin on Thursday, November 1
Share Issue/Capital Change
2018-10-31 English
NeuroVive receives KL1333 clinical trial regulatory approval
Regulatory Filings
2018-10-10 English
NeuroVive får regulatoriskt godkännande för klinisk KL1333-studie
Regulatory Filings
2018-10-10 Swedish
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmaceutical (NVP)
Regulatory Filings FY 2018
2018-10-05 English
NeuroVive reports first NeuroSTAT clinical efficacy signal in TBI
Regulatory Filings
2018-10-04 English
NeuroVive rapporterar en första signal om klinisk effekt av NeuroSTAT vid traumatisk hjärnskada
Earnings Release FY 2018
2018-10-04 Swedish
NeuroVive receives positive FDA feedback on its NeuroSTAT TBI development plan
Regulatory Filings
2018-09-06 English
NeuroVive får positivt utlåtande från FDA om sin utvecklingsplan för NeuroSTAT mot TBI
Regulatory Filings
2018-09-06 Swedish
Earnings Release 2018
Earnings Release H2 2018
2018-08-21 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H2 2018
2018-08-21 English
NeuroVive out-licenses targeted LHON therapy to BridgeBio Pharma’s new subsidiary Fortify Therapeutics
Capital/Financing Update
2018-06-18 English
NeuroVive utlicensierar målinriktad behandling av LHON till BridgeBio Pharmas nya dotterföretag Fortify Therapeutics
Regulatory Filings
2018-06-18 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-06-01 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-31 English
Ändring av antal aktier och röster i NeuroVive Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2018-05-31 Swedish
Information regarding trading of warrants issued by NeuroVive
Share Issue/Capital Change
2018-05-29 English
Information rörande handel med teckningsoptioner utgivna av NeuroVive
Report Publication Announcement
2018-05-29 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-22 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-22 English
NeuroVive och Yungjin rapporterar positiva resultat från klinisk fas I-studie med KL1333 och banar därmed väg för fortsatt klinisk utveckling
Earnings Release FY 2018
2018-05-21 Swedish
NeuroVive and Yungjin reports positive KL1333 phase I clinical study results paving the way for further clinical development
Earnings Release FY 2018
2018-05-21 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-18 English
Rättelse: Beslut vid årsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2018-04-27 Swedish
Amendment: Resolutions from Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
AGM Information
2018-04-27 English
NeuroVive offentliggör tilläggsprospekt
Report Publication Announcement
2018-04-20 Swedish
NeuroVive publishes supplementary prospectus
Report Publication Announcement
2018-04-20 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-04-19 English
NeuroVives KL1333 beviljas särläkemedelsklassificering av FDA för behandling av mitokondriella sjukdomar
Regulatory Filings
2018-04-18 Swedish
NeuroVive’s KL1333 receives FDA Orphan Drug Designation for treatment of mitochondrial diseases
Regulatory Filings
2018-04-18 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements
2018-04-17 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-04-16 English
NeuroVive publishes prospectus in connection with preferential rights issue
Capital/Financing Update
2018-04-09 English
NeuroVive offentliggör prospekt med anledning av företrädesemission
Capital/Financing Update
2018-04-09 Swedish
NeuroVive Pharmaceutical publicerar årsredovisningen för 2017
Annual Report FY 2017
2018-03-26 Swedish
Annual Report 2017
Annual Report FY 2017
2018-03-26 Swedish
NeuroVive Pharmaceutical AB publishes 2017 Annual report
Annual Report FY 2017
2018-03-26 English
NeuroVive Pharmaceutical AB (publ): kommuniké från extra bolagsstämma
AGM Information
2018-03-22 Swedish
NeuroVive Pharmaceutical AB (publ): report from EGM
Capital/Financing Update
2018-03-22 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-03-07 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q4 2017
2018-02-20 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q4 2017
2018-02-20 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-16 English
Kallelse till extra bolagsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2018-02-15 Swedish
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
AGM Information
2018-02-15 English
NeuroVive rapporterar genombrott för projekt inom mitokondriell myopati
Regulatory Filings
2018-01-29 Swedish
NeuroVive reports breakthrough in mitochondrial myopathy project
Regulatory Filings
2018-01-29 English